scholarly journals Estradiol treatment or modest exercise improves hepatic health and mitochondrial outcomes in female mice following ovariectomy

Author(s):  
Kelly N. Z. Fuller ◽  
Colin S. McCoin ◽  
Alex T. Von Schulze ◽  
Claire J. Houchen ◽  
Michael A. Choi ◽  
...  

We recently reported that compared to males, female mice have increased hepatic mitochondrial respiratory capacity and are protected against high-fat diet-induced steatosis. Here we sought to determine the role of estrogen in hepatic mitochondrial function, steatosis, and bile acid metabolism in female mice, as well as investigate potential benefits of exercise in the absence or presence of estrogen via ovariectomy (OVX). Female C57BL mice (n=6 per group) were randomly assigned to sham surgery (Sham), ovariectomy (OVX), or OVX plus estradiol replacement therapy (OVX+Est). Half of the mice in each treatment group were sedentary (SED) or had access to voluntary wheel running (VWR). All mice were fed a high-fat diet (HFD) and were housed at thermoneutral temperatures. We assessed isolated hepatic mitochondrial respiratory capacity using the Oroboros O2k with both pyruvate and palmitoylcarnitine as substrates. As expected, OVX mice presented with greater hepatic steatosis, weight gain, and fat mass gain compared to Sham and OVX+Est animals. Hepatic mitochondrial coupling (Basal/State 3 respiration) with pyruvate was impaired following OVX, but both VWR and estradiol treatment rescued coupling to levels greater than or equal to Sham animals. Estradiol and exercise also had different effects on liver electron transport chain protein expression depending on OVX status. Markers of bile acid metabolism and excretion were also impaired by ovariectomy but rescued with estradiol add-back. Together our data suggest that estrogen depletion impairs hepatic mitochondrial function and liver health, and that estradiol replacement and modest exercise can aid in rescuing this phenotype.

2018 ◽  
Vol 43 (2) ◽  
pp. 329-337 ◽  
Author(s):  
Yuji Tanaka ◽  
Takanori Ikeda ◽  
Kazuo Yamamoto ◽  
Shiori Masuda ◽  
Hiroshi Ogawa ◽  
...  

2019 ◽  
Vol 10 (6) ◽  
pp. 3224-3236 ◽  
Author(s):  
Shiming Huang ◽  
Daorui Pang ◽  
Xiong Li ◽  
Lijun You ◽  
Zhengang Zhao ◽  
...  

This study aimed to evaluate the regulation of lipid metabolism and mechanism of a sulfated polysaccharide from Gracilaria Lemaneiformis (GLP).


2019 ◽  
Vol 65 (1) ◽  
pp. 45-51 ◽  
Author(s):  
Reika YOSHITSUGU ◽  
Keidai KIKUCHI ◽  
Hitoshi IWAYA ◽  
Nobuyuki FUJII ◽  
Shota HORI ◽  
...  

Nutrition ◽  
2019 ◽  
Vol 65 ◽  
pp. 50-59 ◽  
Author(s):  
Qichao Chen ◽  
Min Liu ◽  
Pengyu Zhang ◽  
Shujun Fan ◽  
Jinli Huang ◽  
...  

2020 ◽  
Vol 64 ◽  
pp. 103651 ◽  
Author(s):  
Jinhua Cheng ◽  
Xiujuan Jiang ◽  
Jingwen Li ◽  
Shanshan Zhou ◽  
Tingmei Bai ◽  
...  

Author(s):  
Sik Yu So ◽  
Qinglong Wu ◽  
Kin Sum Leung ◽  
Zuzanna Maria Kundi ◽  
Tor C Savidge ◽  
...  

Emerging evidence links dietary fiber with altered gut microbiota composition and bile acid signaling in maintaining metabolic health. Yeast β-glucan (Y-BG) is a dietary supplement known for its immunomodulatory effect, yet its impact on the gut microbiota and bile acid composition remains unclear. This study investigated whether dietary forms of Y-BG modulate these gut-derived signals. We performed 4-week dietary supplementation in healthy mice to evaluate effects of different fiber composition (soluble vs particulate Y-BG) and dose (0.1 vs. 2%). We found that 2% particulate Y-BG induced robust gut microbiota community shifts with elevated liver Cyp7a1 mRNA abundance and bile acid synthesis. These diet-induced responses were notably different when compared to the prebiotic inulin, and included a marked reduction in fecal Bilophila abundance which we demonstrated as translatable to obesity in population-scale American Gut and TwinsUK clinical cohorts. This prompted us to test whether 2% Y-BG maintained metabolic health in mice fed 60% HFD over 13 weeks. Y-BG consistently altered the gut microbiota composition and reduced Bilophila abundance, with trends observed in improvement of metabolic phenotype. Notably, Y-BG improved insulin sensitization and this was associated with enhanced ileal Glpr1r mRNA accumulation and reduced Bilophila abundance. Collectively, our results demonstrate that Y-BG modulates gut microbiota community composition and bile acid signaling, but the dietary regime needs to be optimized to facilitate clinical improvement in metabolic phenotype in an aggressive high-fat diet animal model.


2020 ◽  
Vol 128 (5) ◽  
pp. 1251-1261
Author(s):  
Kelly N. Z. Fuller ◽  
Colin S. McCoin ◽  
Julie Allen ◽  
Shelby Bell-Glenn ◽  
Devin C. Koestler ◽  
...  

This is the first study focusing on hepatic mitochondrial respiratory outcomes in response to lipid overload via a high-fat diet (HFD) combined with intralipid injection. Novel findings include no effect of intralipid injection on mitochondrial outcomes of interest, despite increased circulating lipid concentrations. However, we report pronounced differences in hepatic mitochondrial respiration, complex protein expression, and H2O2 production by sex and BCL-2/adenovirus EIB 19-kDa interacting protein (BNIP3) genotype. Specifically, female mice had lower H2O2 emission globally and on an acute HFD, females had greater hepatic mitochondrial respiration than males, whereas BNIP3 knockout (KO) animals had greater mitochondrial coupling and complex protein expression than wild-type (WT) animals.


2021 ◽  
Author(s):  
Cong Liang ◽  
Xiao-Hong Zhou ◽  
Pi-Min Gong ◽  
Hai-Yue Niu ◽  
Lin-Zheng Lyu ◽  
...  

Lactiplantibacillus plantarum H-87 shows excellent bile salt hydrolase activity in vitro and effectively prevents obesity by regulating bile acid metabolism to inhibit liver fat accumulation, insulin resistance and lipid digestion in C57BL/6J mice.


2018 ◽  
Vol 315 (5) ◽  
pp. G772-G780 ◽  
Author(s):  
Lino Arisqueta ◽  
Hiart Navarro-Imaz ◽  
Ibone Labiano ◽  
Yuri Rueda ◽  
Olatz Fresnedo

High-fat diet (HFD) feeding or leptin-deficient mice are extensively used as models resembling features of human nonalcoholic fatty liver disease (NAFLD). The concurrence of experimental factors as fat content and source or total caloric intake leads to prominent differences in the development of the hepatic steatosis and related disturbances. In this work, we characterized the hepatic lipid accumulation induced by HFD in wild-type (WT) and ob/ ob mice with the purpose of differentiating adaptations to HFD from those specific of increased overfeeding due to leptin deficiency-associated hyperphagia. Given that most published works have been done in male models, we used female mice with the aim of increasing the body of evidence regarding NAFLD in female subjects. HFD promoted liver lipid accumulation only in the hyperphagic strain. Nevertheless, a decrease of lipid droplet-associated cholesteryl ester (CE) in both WT and obese animals was observed. These changes were accompanied by an improvement in the profile of lipoproteins that transport cholesterol and liver function markers in plasma from ob/ ob mice and a lower hepatic index. Using primary hepatocytes from female mice, overaccumulation of CE induced by 0.4 mM oleic acid reversed in the presence of a specific Takeda G protein-coupled bile acid receptor agonist. Nevertheless, hepatocytes from male mice were not responsive. This study suggests that enterohepatic circulation of bile acids might be one of the factors that can affect sex dimorphism in NAFLD development, which underlines the importance of including female models in the NAFLD research field. NEW & NOTEWORTHY This work provides new insight into the use of high-fat diet as a model to induce nonalcoholic fatty liver disease in wild-type and ob/ ob female mice. We show that high-fat diet induces steatosis only in ob/ ob mice while, surprisingly, several health indicators improve. Noteworthy, experiments with primary hepatocytes from male and female mice show that they express Takeda G protein-coupled bile acid receptor and that it and bile acid enterohepatic circulation might be accountable for sex dimorphism in nonalcoholic fatty liver disease development.


Sign in / Sign up

Export Citation Format

Share Document